1 authorised product containing Insulin degludec, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Xultophy 100 units/mL + 3.6 mg/mL solution for injection. EU/1/14/947/001-004 |
Insulin degludec, Liraglutide | Novo Nordisk A/S | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.